StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research note published on Friday. The firm issued a hold rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Stock Down 7.0 % BCLI stock opened at $0.54 on Friday. Brainstorm Cell Therapeutics has a 52-week low of $0.13 and […]
BCLI Stock Earnings: Brainstorm Cell Reported Results for Q1 2024 biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
Imunon, Inc (NASDAQ:IMNN) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Free Report) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 1,990,000 shares, an increase of 48.5% from the March 31st total of 1,340,000 shares. Based on an average daily volume of 987,100 shares, the short-interest […]
BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn s® Phase 3 Clinical Trial in ALS streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.